Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKinsey
Cerilliant
Chinese Patent Office
Argus Health
Express Scripts
Moodys
Baxter
Cantor Fitzgerald

Generated: November 16, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin degludec

« Back to Dashboard

insulin degludec

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk 0169-2550-13 3 SYRINGE, PLASTIC in 1 CARTON (0169-2550-13) > 3 mL in 1 SYRINGE, PLASTIC
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk 0169-2550-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2550-97) > 3 mL in 1 SYRINGE, PLASTIC
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk 0169-2660-15 5 SYRINGE, PLASTIC in 1 CARTON (0169-2660-15) > 3 mL in 1 SYRINGE, PLASTIC
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk 0169-2660-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2660-97) > 3 mL in 1 SYRINGE, PLASTIC
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Chubb
Healthtrust
McKinsey
QuintilesIMS
US Department of Justice
Mallinckrodt
Dow